References
- BHIVA –British HIV Association. (2012). BHIVA guidelines for the treatment of HIV-1 infected adults with antiretroviral therapy 2012. Draft 4th February, 2012.
- Bourdillon, F., Cadore, B., Dozon, J.-P., Gaudin, P., Hesnault-Pruniau, N., Kapusta-Palmer, C., & Rozenbaum, W. (2009). Opinions and recommendations regarding the potential for treatment as an innovative tool for fighting the HIV epidemic. Conseil national du sida. Retrieved from http://www.giv.org.br/divulgacao/intransmissivel/FrancaAvis_sur_l_interetIngles.pdf
- Champenois, K., & Yazdanpanah, Y. (2012). Dépistage du VIH, stratégie ciblée ou généralisée. La Lettre de l'Infectiologie, 27(4), 144–145. Retrieved from http://www.edimark.fr/publications/articles/18822.pdf.
- DHHS –Department of Health and Human Services. (2012). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
- Garnett, G. P., Becker, S., & Bertozzi, S. (2012). Treatment as prevention: Translating efficacy trial results to population effectiveness. Current Opinion in HIV and AIDS, 7, 157–163. doi:10.1097/COH.0b013e3283504ab7
- Hirnschall, G., & Schwartländer, B. (2011). Treatment 2.0: Catalysing the next phase of scale-up. The Lancet, 378, 209–211. doi:10.1016/S0140-6736(11)60247-X
- Hsieh, H.-F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15, 1277–1288. doi:10.1177/1049732305276687
- Lockman, S., & Sax, P. (2012). Treatment-for-prevention: Clinical considerations. Current Opinion in HIV and AIDS, 7, 131–139. doi:10.1097/COH.0b013e32834fcf6b
- Department of Health and Sports. (2010). Plan national de lutte contre le VIH/SIDA et les ITS 2010–2014. France: République Française. Retrieved from http://www.sante.gouv.fr/IMG/pdf/plan_national_lutte_contre_le_VIH-SIDA_et_les_IST_2010–2014.pdf
- Pialoux, G., Lert, F., Girard, G., & Yvers, E. (2009). Mission RDRs: Prévention et réduction des risques dans les groupes à haut risque vis-à-vis du VIH et des IST. Paris:Direction Générale de la Santé.
- Reproductive Health Matters. (2009). Disagreement re promoting HIV treatment as prevention in France. Round Up: HIV and AIDS. Reproductive Health Matters, 17(34), 221–224. doi:10.1016/S0968-8080(09)34489-4
- Yeni, P., et al. (2010). Prise en charge médicale des personnes infectées par le VIH: Recommandations du groupe d'experts. Department of Health and Sports. Paris: La Documentation Française.